Jeffrey Ives

Jeffrey Ives

Directeur/Membre du Conseil chez ACUMEN PHARMACEUTICALS, INC.

Fortune : 34 176 $ au 30/06/2026

75 ans
Health Technology
Consumer Services
Finance

Profil

Jeffrey L.
Ives
is currently Independent Director at Acumen Pharmaceuticals, Inc. since 2014, Director at Astrocyte Pharmaceuticals, Inc. since 2014, and Principal at Neuropharma Advisors LLC since 2013.
Former positions include Chief Executive Officer & Director at Satori Pharmaceuticals, Inc. from 2009 to 2013, Director & Vice President-Business Development at Celgene Corp., Independent Director at CARA Therapeutics, Inc., Director at Pinteon Therapeutics, Inc., Director at Orthogonal Neuroscience (US), Inc., Senior Vice President at Pfizer Inc. from 2001 to 2007, Executive-in-Residence at PureTech Health LLC, Senior Vice President-Research Portfolio at Pfizer (St. Louis) from 2001 to 2007, and Venture Partner at New Leaf Venture Partners LLC from 2017 to 2021.
Education includes undergraduate studies at Colgate University and graduate and doctorate degrees from Yale University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/06/2026 12 800 ( 0,02 % ) 34 176 $ 30/06/2026

Postes actifs de Jeffrey Ives

SociétésPosteDébut
ACUMEN PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/05/2014
Neuropharma Advisors LLC
Corporate Officer/Principal 01/09/2013
Directeur/Membre du Conseil 01/12/2014

Anciens postes connus de Jeffrey Ives

SociétésPosteFin
Private Equity Investor 01/03/2021
Directeur Général 01/01/2013
Corporate Officer/Principal 01/01/2007
PFIZER INC. Corporate Officer/Principal 01/01/2007
Voir l'expérience en détail de Jeffrey Ives

Formation de Jeffrey Ives

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

83

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Neuropharma Advisors LLC

Health Technology

  1. Bourse
  2. Insiders
  3. Jeffrey Ives
🔇